Meloxicam Market, By Product Type (Tablets, Capsules, Syrup or Oral Suspension, and Injectable Solutions), By Indication (Osteoarthritis, Rheumatoid arthritis, Juvenile rheumatoid arthritis (pediatric arthritis), and Other musculoskeletal or inflammatory disorders), By Dosage Strength (7.5 mg, 15 mg, and Other strengths (e.g., 5 mg, 10 mg)), By Route of Administration (Oral and Parenteral), By Drug Type (Branded and Generic), By Age Group (Adults, Pediatric, and Geriatric), By End User (Hospitals and Clinics, Specialty Clinics, Homecare Settings, Research and Academic Institutes, and Others (long-term care, nursing homes, etc.)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography ( North America, Latin America, Europe, Asia Pacific, Middle East, Africa)